This trend was also observed for CYFRA21‐1 and PRO‐GRP, with NSCLC patients showing higher median levels, although the difference for CYFRA21‐1 did not reach statistical significance ( Z = −1.56, p = 0.120).
← all excerpts
Integrating Clinical Features, Laboratory Biomarkers and Computed Tomography for the Discrimination of Non-Small Cell Lung Cancer and Benign Pulmonary Diseases: A Clinical Prediction Model.
1
0.1200
0.1200